Check-Cap Ltd.
NASDAQ:CHEK
Overview | Financials
Company Name | Check-Cap Ltd. |
Symbol | CHEK |
Currency | USD |
Price | 1.55 |
Market Cap | 9,068,058 |
Dividend Yield | 0% |
52-week-range | 0.56 - 3.45 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Alex Ovadia |
Website | https://www.check-cap.com |
An error occurred while fetching data.
About Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD